Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

A brand-new paper has just been published that claims to challenge the century-old dogma that Alzheimer’s disease is irreversible. That’s a big claim—and big claims demand strong ...

Last year, the National Institute of Health and Care Excellence (Nice) rejected the NHS rollout of the first two drugs – lecanemab and donanemab – that were found to halt the progression of disease.

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

For decades, Alzheimer’s disease has been framed as a one‑way slide, a slow erasure of memory that medicine could at best delay. That narrative is starting to crack. A wave of lab discoveries, smarter ...

Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting its potential as a non-invasive Alzheimer’s therapy. Scientists at the Kunmi ...

A protein in the brain may hold new hope for Alzheimer’s patients, and the discovery comes from a Norwegian research team working closely with Chinese partners, University of Oslo reports.

A significant new study from the Fang-Stavem Lab at the University of Oslo and Akershus University Hospital have made a novel discovery on the ...

Alzheimer’s Research UK are calling on the government to work with industry, researchers and the NHS to set up pilot trials.